Zobrazeno 1 - 10
of 1 680
pro vyhledávání: '"PHiD-CV"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
Background In response to the substantial clinical and economic burden of diseases caused by Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) in Tunisia, the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D
Externí odkaz:
https://doaj.org/article/cddce0097de54bbb90675bec9de910c3
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1 (2022)
The worldwide implementation of pneumococcal conjugate vaccines (PCVs) in children has reduced the overall pneumococcal disease burden. Two PCVs are widely available for infant vaccination: the pneumococcal non-typeable Haemophilus influenzae protein
Externí odkaz:
https://doaj.org/article/e7e8c051894e44108026f09e5e0f850a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zaman, Khalequ, Zaman, Sheikh Farzana, Zaman, Farzana, Aziz, Asma, Faisal, Sayeed-Bin, Traskine, Magali, Habib, Md Ahsan, Ruiz-Guiñazú, Javier, Borys, Dorota
Publikováno v:
In Vaccine 29 January 2018 36(5):698-706
Autor:
Alen Marijam, Lode Schuerman, Patricia Izurieta, Priya Pereira, Désirée Van Oorschot, Shailesh Mehta, Martin OC Ota, Baudouin Standaert
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 7 (2022)
Vaccine impact models against rotavirus disease (RD) and pneumococcal disease (PD) in low- and middle-income countries assume vaccine coverage based on other vaccines. We propose to assess the impact on severe disease cases and deaths avoided based o
Externí odkaz:
https://doaj.org/article/afd6497327b841c0864297205ae2eb94
Publikováno v:
Expert Review of Vaccines, Vol 17, Iss 9, Pp 797-818 (2018)
Introduction: Pneumococcal diseases (including septicemia, meningitis, pneumonia, and upper respiratory infections) constitute a major public health problem. The World Health Organization recommends pneumococcal conjugate vaccine immunization of youn
Externí odkaz:
https://doaj.org/article/d9b490393f384a3780369588927ace39
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 1, Pp 85-94 (2018)
Background: Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) can cause invasive pneumococcal diseases (IPD), pneumonia, and acute otitis media (AOM). Both the 10-valent pneumococcal NTHi protein D conjugate vaccine (PHiD-CV) an
Externí odkaz:
https://doaj.org/article/6366888e35cc4811a55afc21b2bcba2f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Soon Min Lee, Jang Hoon Lee, Eun Song Song, Sung Jin Kim, Joon Hyung Kim, Rupert W. Jakes, Raghavendra Devadiga, Moon Sung Park
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 12, Pp 3019-3025 (2018)
In 2010, Korea introduced 10-valent pneumococcal conjugate vaccine for children aged 6 weeks to 5 years against invasive disease caused by Streptococcus pneumoniae serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, 23F and cross-reactive 19A. The aim of th
Externí odkaz:
https://doaj.org/article/e5785d6caeec4b138d23b7ce8ab45c35
Autor:
Paolo Castiglia, Lorenzo Pradelli, Stefano Castagna, Veronica Freguglia, Giorgio Palù, Susanna Esposito
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 10, Pp 2307-2315 (2017)
Pneumococcal diseases are associated with a significant clinical and economic burden. The 7-valent pneumococcal conjugate vaccine (PCV-7) has been used for the immunization of newborns against invasive pneumococcal diseases (IPD) in Italy while now,
Externí odkaz:
https://doaj.org/article/1fa4f69cbaa54c8a93ab8124cd2e5efc